DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 117.39 USD 0.09% Market Closed
Market Cap: 8.3B USD

Intrinsic Value

The intrinsic value of one DVA stock under the Base Case scenario is 265.23 USD. Compared to the current market price of 117.39 USD, DaVita Inc is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DVA Intrinsic Value
265.23 USD
Undervaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
DaVita Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about DVA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DVA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for DaVita Inc.

Explain Valuation
Compare DVA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heavy reliance on Medicare and Medicaid reimbursement rates significantly exposes DaVita’s profitability to U.S. federal budget changes; any unfavorable regulation or reduced rate hikes could compress margins more than expected.

Acute staffing pressures and labor cost inflation threaten operational efficiency—DaVita’s specialized workforce requirements may drive operational disruptions or limit the company’s ability to expand dialysis centers profitably.

Expanding competition from smaller clinic networks and hospital-based providers could challenge DaVita’s market share, especially if payers direct patients toward lower-cost or integrated care models.

Bull Theses

DaVita’s large-scale network of outpatient dialysis centers creates barriers to entry, giving the company significant negotiating power with suppliers and payers and helping stabilize its profitability in the long run.

The ongoing shift toward value-based care and integrated kidney care provides DaVita an opportunity to leverage its care coordination capabilities, potentially generating higher patient retention and incremental revenue streams.

Strong recurring revenue from chronic dialysis treatments, combined with a stable end-stage renal disease patient base, underpins DaVita’s predictable cash flows and supports strategic reinvestments in technology and care innovation.

Show More Less
How do you feel about DVA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DaVita Inc

Current Assets 4.1B
Cash & Short-Term Investments 736.5m
Receivables 3B
Other Current Assets 389.5m
Non-Current Assets 13.4B
Long-Term Investments 299.6m
PP&E 5.2B
Intangibles 7.8B
Other Non-Current Assets 204.5m
Current Liabilities 3B
Accounts Payable 655.6m
Accrued Liabilities 1.3B
Other Current Liabilities 1.1B
Non-Current Liabilities 15.1B
Long-Term Debt 10.2B
Other Non-Current Liabilities 4.9B
Efficiency

Free Cash Flow Analysis
DaVita Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
DaVita Inc

Revenue
13.3B USD
Cost of Revenue
-9.1B USD
Gross Profit
4.3B USD
Operating Expenses
-2.3B USD
Operating Income
1.9B USD
Other Expenses
-1.2B USD
Net Income
771.9m USD
Fundamental Scores

DVA Profitability Score
Profitability Due Diligence

DaVita Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
ROIC is Increasing
50/100
Profitability
Score

DaVita Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

DVA Solvency Score
Solvency Due Diligence

DaVita Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
41/100
Solvency
Score

DaVita Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DVA Price Targets Summary
DaVita Inc

Wall Street analysts forecast DVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVA is 141.36 USD with a low forecast of 127.26 USD and a high forecast of 157.5 USD.

Lowest
Price Target
127.26 USD
8% Upside
Average
Price Target
141.36 USD
20% Upside
Highest
Price Target
157.5 USD
34% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

DaVita Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DVA Insider Trading
Buy and sell transactions by insiders

DVA News

Other Videos
What is the Intrinsic Value of one DVA stock?

The intrinsic value of one DVA stock under the Base Case scenario is 265.23 USD.

Is DVA stock undervalued or overvalued?

Compared to the current market price of 117.39 USD, DaVita Inc is Undervalued by 56%.

Back to Top